WHO ICTRP trial
A population pharmacokinetic/pharmacodynamic study of liposomal bupivacaine…
ChiCTR2500099289 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500099289 |
|---|---|
| Public title | A population pharmacokinetic/pharmacodynamic study of liposomal bupivacaine receiving thoracic paravertebral analgesia after thoracic surgery |
| Scientific title | Study of the efficacy and safety of bupivacaine liposome in the treatment of thoracic paravertebral analgesia and population pharmacokinetics/pharmacodynamics |
| Primary sponsor | Beijing Chest Hospital Affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Acute postoperative chest pain |
| Interventions | The group of bupivacaine liposomal:Thoracic paravertebral analgesia with liposomal bupivacaine |
| Registration date | Mar 20, 2025 |
| Target size | The group of bupivacaine liposomal:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: